Q2 Earnings Forecast for Revvity Issued By Leerink Partnrs

Revvity, Inc. (NYSE:RVTY) – Equities research analysts at Leerink Partnrs reduced their Q2 2025 EPS estimates for Revvity in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings of $1.14 per share for the quarter, down from their prior estimate of $1.22. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity’s Q3 2025 earnings at $1.25 EPS, Q1 2026 earnings at $1.15 EPS and Q3 2026 earnings at $1.39 EPS.

RVTY has been the topic of a number of other reports. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a research note on Friday, January 10th. Barclays decreased their price objective on Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Robert W. Baird reduced their target price on Revvity from $127.00 to $125.00 and set an “outperform” rating on the stock in a research report on Tuesday. The Goldman Sachs Group lowered their price target on Revvity from $140.00 to $125.00 and set a “buy” rating for the company in a report on Tuesday. Finally, Raymond James reaffirmed an “outperform” rating and issued a $120.00 target price (down previously from $145.00) on shares of Revvity in a research report on Tuesday. Four investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $126.46.

Revvity Stock Down 1.4 %

Shares of RVTY opened at $93.34 on Wednesday. The stock has a fifty day simple moving average of $103.67 and a two-hundred day simple moving average of $112.54. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $11.21 billion, a PE ratio of 42.24, a price-to-earnings-growth ratio of 3.82 and a beta of 1.07. Revvity has a 52-week low of $88.53 and a 52-week high of $129.50.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.05. The business had revenue of $664.76 million during the quarter, compared to analyst estimates of $662.30 million. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The business’s revenue was up 2.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 earnings per share.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.30%. Revvity’s dividend payout ratio (DPR) is presently 11.91%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Nissay Asset Management Corp Japan ADV raised its stake in Revvity by 0.6% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company’s stock valued at $1,682,000 after acquiring an additional 91 shares during the last quarter. Quarry LP grew its stake in shares of Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company’s stock valued at $34,000 after purchasing an additional 95 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Revvity by 2.4% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 4,214 shares of the company’s stock valued at $470,000 after purchasing an additional 100 shares during the period. HB Wealth Management LLC raised its stake in shares of Revvity by 4.6% during the fourth quarter. HB Wealth Management LLC now owns 2,380 shares of the company’s stock worth $266,000 after purchasing an additional 104 shares during the last quarter. Finally, Signaturefd LLC raised its stake in shares of Revvity by 6.8% during the fourth quarter. Signaturefd LLC now owns 1,668 shares of the company’s stock worth $186,000 after purchasing an additional 106 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.